Structure Therapeutics (GPCR) Amortizatization of Intangibles (2023 - 2026)
Structure Therapeutics' (GPCR) quarterly Amortizatization of Intangibles came in at $10000.0 in Q1 2026, down 96.89% quarter-over-quarter from $322000.0 in Q4 2025.
Structure Therapeutics (GPCR) Amortizatization of Intangibles (2023 - 2026) Analysis & Trends
Structure Therapeutics' Amortizatization of Intangibles history runs 4 years deep, the most recent figure standing at $10000.0 for Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles changed N/A year-over-year to $10000.0 in Q1 2026; TTM through Mar 2026 was $342000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $345000.0, up 8525.0% from the prior year.
- Amortizatization of Intangibles eased to $10000.0 in Q1 2026 per GPCR's latest filing, from $322000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $322000.0 in Q4 2025 and bottomed at -$7000.0 in Q4 2024.
- The 4-year median for Amortizatization of Intangibles is $13500.0 (2023), against an average of $85500.0.
- Across the five-year window, Amortizatization of Intangibles sank 141.18% in 2024 and surged 4700.0% in 2025, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $17000.0 in 2023, then plunged by 141.18% to -$7000.0 in 2024, then jumped by 4700.0% to $322000.0 in 2025, then sank by 96.89% to $10000.0 in 2026.
- Per Business Quant, the three latest GPCR Amortizatization of Intangibles figures stand at $10000.0 (Q1 2026), $322000.0 (Q4 2025), and -$7000.0 (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Structure Therapeutics | 10.63 Bn | 10.63 Bn | - | 10,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10,000.00 |
| Mar 31, 2026 | 10,000.00 |
| Dec 31, 2025 | 322,000.00 |
| Dec 31, 2025 | 322,000.00 |
| Dec 31, 2024 | -7,000.00 |
| Dec 31, 2024 | -7,000.00 |
| Dec 31, 2023 | 17,000.00 |
| Dec 31, 2023 | 17,000.00 |